PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $160.0M | $154.0M | $200.5M | $128.3M | $130.5M |
| Gross profit | $45.8M | $37.3M | $52.8M | $49.0M | $58.9M |
| Operating income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M |
| Operating expenses | $599.6M | $511.6M | $387.2M | $356.2M | $269.3M |
| Cost of revenue | $114.2M | $116.7M | $147.7M | $79.3M | $71.7M |
| Cash from operations | -$111.2M | -$206.1M | -$259.2M | -$263.2M | -$111.2M |
| Capital expenditure | $2.7M | $6.2M | $8.8M | $16.8M | $5.9M |
| Free cash flow | -$113.9M | -$212.2M | -$268.0M | -$280.0M | -$117.1M |
| Impairments | — | $144.5M | — | — | — |
| Total assets | $784.1M | $1.3B | $1.7B | $1.8B | $2.0B |
| Total liabilities | $778.7M | $753.9M | $1.0B | $1.2B | $1.2B |
| Total debt | — | — | — | $900.0M | $900.0M |
Shares outstanding 310.6M · Free float 88.1%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.